Özgür ÇELEBİ
(Tıbbi Mikrobiyoloji Anabilim Dalı, Atatürk Üniversite Tıp Fakültesi, Erzurum Türkiye)
Demet ÇELEBİ
(Tıbbi Mikrobiyoloji Anabilim Dalı, Atatürk Üniversite Veteriner Fakültesi, Erzurum, Türkiye)
Yıl: 2021Cilt: 53Sayı: 2ISSN: 1308-8734 / 1308-8742Sayfa Aralığı: 123 - 126İngilizce

20 0
Viral Respiratory Tract Pathogens During the COVID-19 Pandemic
Objective: This study aimed to report viral respiratory pathogens during the coronavirus disease 2019(COVID-19) pandemic.Materials and Methods: Other viral pathogens were identified. COVID-19 immunoglobulin M and immunoglobulin G were detected.Results: Of the 56 samples collected from women, 2 (3.5%) were positive for severe acute respiratorysyndrome coronavirus 2 (SARS-CoV-2), whereas 8 (10%) of the 80 samples from men were positive forSARS-CoV-2. The number of respiratory syncytial virus-A–positive cases was 6 (10.7%) in women and 14(17.5%) in men. Two (3.5%) of the women were positive for parainfluenza-3, and 6 of the men were positivefor influenza-B. The number of human metapneumovirus (HMPV)–positive women and men was 6 (10.7%)and 6 (7.5%), respectively. Rhinovirus caused 14.2% and 10% of the cases in men and women, respectively.With a ratio of 10.7% in women and 7.5% in men; SARS-CoV-2, with a ratio of 10% in men and 3.5% inwomen; influenza-B, with a ratio of 7.5% in men; and parainfluenza-3 and 4, with a ratio of 3.5% in women.SARS-CoV-2 had a mean incidence rate of 7% in men and women. The antibody screening results reveal thatantibody formation did not occur in 3 women among the 10 patients who were diagnosed with COVID-19,and antibody formation occurred in 2 of 7 men. Antibody formation occurred in 5 women (16.6%) and 7men (20.5%) among the 58 patients who were positive for other respiratory tract pathogens. However, 23(29.5%) of the blood samples collected from 78 individuals who were negative for the COVID-19 agent andother respiratory tract viral pathogens were positive for the COVID-19 antibody.Conclusion: Because the climate is colder than normal in areas settled at higher altitudes, more than onepathogens act together. In addition, respiratory infections are seen in all seasons. This causes the diseases tobe fewer and milder than in other regions.
DergiAraştırma MakalesiErişime Açık
  • 1. Heikkinen T, Järvinen A. The common cold. Lancet. 2003;361(9351):51-59. [Crossref]
  • 2. Shulman ST, Bisno AL, Clegg HW, et al. Clinical practice guideline for the diagnosis and management of group A streptococcal pharyngitis: 2012 update by the Infectious Diseases Society of America. Clin Infect Dis. 2012;55(10):e86-e102. [Crossref]
  • 3. Bisno AL, Gerber MA, Gwaltney JM Jr, Kaplan EL, Schwartz RH, Infectious Diseases Society of America. Practice guidelines for the diagnosis and management of group A streptococcal pharyngitis. Infectious Diseases Society of America. Clin Infect Dis. 2002;35(2):113-125. [Crossref]
  • 4. Wald ER. Microbiology of acute and chronic sinusitis in children and adults. Am J Med Sci. 1998;316(1):13-20. [Crossref]
  • 5. Parri FM, Neu HC, Connelly JV. Infectious diseases. In: Rakel RE, editor. Textbook of Family Practice. Philadelphia: W.B. Saunders Company; 1995:317-392.
  • 6. Purssell E. Upper respiratory tract infection in infants from a nutritional perspective. J Fam Health Care. 2009;19(5):164-168.
  • 7. T.C. Sağlık Bakanlığı RSHMB Hıfzıssıhha Mektebi Müdürlüğü. Ulusal Hastalık Yükü ve MaliyetEtkililik Projesi Hastalık Yükü Final Rapor. 1 ed. Ankara: 2004.
  • 8. World Health Organization. World Health Statistics 2011. WHO, Geneva. http:// https:// www.who.int/gho/publications/world_health_ statistics/EN_WHS2011_Full.pdf
  • 9. Zumla A. Killer respiratory tract infections: time to turn the tide. Curr Opin Pulm Med. 2012;18(3):173-174. [Crossref]
  • 10. Tregoning JS, Schwarze J. Respiratory viral infections in infants: causes, clinical symptoms, virology, and immunology. Clin Microbiol Rev. 2010;23(1):74-98. [Crossref]
  • 11. Kesson AM. Respiratory virus infections. Paediatr Respir Rev. 2007;8(3):240-248.
  • 12. Li Q, Guan X, Wu P et al. Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia. N Engl J Med. 2020;382(13):1199-1207. [Crossref]
  • 13. World Health Organization. Cumulative Number of Reported Probable Cases of Severe Acute Respiratory Syndrome (SARS). 2020. (Available from: https://www.who.int/health-topics/severeacute-respiratory-syndrome#tab=tab_1)
  • 14. World Health Organization. WHO 2019, Middle East respiratory syndrome coronavirus (MERS-CoV). January 19, 2019. https://www. who.int/emergencies/mers-cov/en/.
  • 15. Hak E, Rovers MM, Kuyvenhoven MM, Schellevis FG, Verheij TJ. Incidence of GP-diagnosed respiratory tract infections according to age, gender and high-risk co-morbidity: the Second Dutch National Survey of General Practice. Fam Pract. 2006;23(3):291-294. [Crossref]
  • 16. Jin Y, Zhang RF, Xie ZP, et al. Newly identified respiratory viruses associated with acute lower respiratory tract infections in children in Lanzou, China, from 2006 to 2009. Clin Microbiol Infect. 2012;18(1):74-80. [Crossref]
  • 17. Akçalı S, Yılmaz N, Güler Ö, Şanlıdağ T, Anıl M. Alt solunum yolu enfeksiyonu olan çocuklarda solunum yolu viral etkenlerinin sıklığı. Turk Arch Ped. 2013;48(3):215-220. [Crossref]
  • 18. Sancaklı Ö, Yenigün A, Kırdar S. Alt solunum yolu enfeksiyonunda nazofaringeal örneklerde polimeraz zincir reaksiyonu sonuçları. J Pediatr Inf. 2012;6(3):84-89. [Crossref]
  • 19. World Health Organization. Middle East respiratory syndrome coronavirus (MERS-CoV). 2016. Accessed August 1, 2016. http://www.who.int/ emergencies/mers-cov/en/.
  • 20. McIntosh, Perlman S. Coronaviruses, including Severe Acute Respiratory Syndrome (SARS) and Middle East Respiratory Syndrome (MERS) In: Bennett JE, Dolin R, Blaser MJ (eds). Principles and Practice of Infectious Diseases. 8th edition. Philadelphia: Elsevier-Saunders; 2015,1928-1936.
  • 21. Ivaska L, Niemela J, Heikkinen T, Vuorinen T, Peltola V. Identification of respiratory viruses with a novel point-of-care multianalyte antigen detection test in children with acute respiratory tract infection. J Clin Virol. 2013;57(2):136-140. [Crossref]
  • 22. Xu X, Chen P, Wang J, et al. Evolution of the novel coronavirus from the ongoing Wuhan outbreak and modeling of its spike protein for risk of human transmission. Sci China Life Sci. 2020;63(3):457-460. [Crossref]
  • 23. Cui J, Li F, Shi ZL. Origin and evolution of pathogenic coronaviruses. Nat Rev Microbiol. 2019;17(3):181–192. [Crossref]
  • 24. Li W, Sui J, Huang, IC, et al. The S proteins of human coronavirus NL63 and severe acute respiratory syndrome coronavirus bind overlapping regions of ACE2. Virology. 2007:367(2):367– 374. [Crossref]
  • 25. Zhou P, Yang XL, Wang XG, et al. Discovery of a novel coronavirus associated with the recent pneumonia outbreak in humans and its potential bat origin. Nature. 2020;579:270-273. [Crossref]
  • 26. Zhu N, Zhang D, Wang W, et al. A novel coronavirus from patients with pneumonia in China, 2019. N Engl J Med. 2020;382:727–733. [Crossref]
  • 27. American Academy of Pediatrics, Subcommittee on Management of Sinusitis and Committee on Quality Improvement. Clinical practice guideline: management of sinusitis. Pediatrics. 2001;108(3):798-808. [Crossref]
  • 28. Altun B, Gür D. Hacettepe Üniversitesi Çocuk Hastanesi’nde klinik örneklerden izole edilen haemophilus influenzae suşlarının antibiyotiklere direnç durumu (2002-2007). Çocuk Enfeksiyonları Dergisi. 2008;2(2):50-54.
  • 29. Huang C. Wang Y, Li X, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395(10223):497- 506. [Crossref]
  • 30. Shi Y, Yu X, Zhao H, Wang H, Zhao R, Sheng J. Host susceptibility to severe COVID-19 and establishment of a host risk score: findings of 487 cases outside Wuhan. Crit Care. 2020;24(1):108. [Crossref]

TÜBİTAK ULAKBİM Ulusal Akademik Ağ ve Bilgi Merkezi Cahit Arf Bilgi Merkezi © 2019 Tüm Hakları Saklıdır.